Investors Meet

Board & Shareholder Meetings View source PDF

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.2%1-day move

₹435.00

prior close

₹436.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.1+1.2+1.2+0.8-1.2-0.9-1.4-1.2-2.4-0.9-2.2+3.4-2.1—

Up moveDown movePending

AI summary

Cohance Lifesciences Ltd (formerly Suven Pharmaceuticals Limited) has disclosed that its management will attend three upcoming investor conferences: 360 ONE Capital's 16th Annual Investor Conference on May 29, 2026 in Mumbai, BofA Healthcare Tour on June 4 in Hyderabad, and Goldman Sachs CRO/CDMO Tour on June 11. The 360 ONE Capital meeting was rescheduled from May 27 to May 29. The company clarified that no unpublished price-sensitive information will be shared during these interactions.

Likely market impact

This is a routine regulatory disclosure showing active investor relations engagement with major institutional investors. The participation in multiple healthcare-focused conferences suggests continued interest from institutional investors, though no material price-sensitive information is being disclosed.